These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 4292024)
41. [Estriol succinate and its effect on the contractility of the human uterus during the climateric]. Romero-Salinas ; Quiróz-Jiménez Ginecol Obstet Mex; 1978 Apr; 43(258):269-78. PubMed ID: 689426 [No Abstract] [Full Text] [Related]
42. Intranasal oestrogen cream for the prevention of epistaxis in patients with bleeding disorders. Ross CS; Pruthi RK; Schmidt KA; Eckerman AL; Rodriguez V Haemophilia; 2011 Jan; 17(1):164. PubMed ID: 20609012 [No Abstract] [Full Text] [Related]
43. A simple test for the luteinizing hormone releasing function of hypothalamo-pituitary axis using conjugated estrogen and its clinical evaluation. Kusuda M; Kumamoto H Acta Obstet Gynaecol Jpn; 1973 Jul; 20(3):149-58. PubMed ID: 4376325 [No Abstract] [Full Text] [Related]
44. Estrogen treatment improves arterial distensibility, fibrinolysis, and metabolic profile in postmenopausal women with type 2 diabetes mellitus. Sztejnsznajd C; Silva ME; Nussbacher A; Gebara OE; D'Amico EA; Rocha DM; da Rocha TR; Santos RF; Wajngarten M; Fukui RT; Correia MR; Wajchenberg BL; Ursich MJ Metabolism; 2006 Jul; 55(7):953-9. PubMed ID: 16784970 [TBL] [Abstract][Full Text] [Related]
45. Effect of progestogen (lynoestrenol) on abnormal uterine bleeding. Dutta A; Sen PN; Banerjee T J Indian Med Assoc; 1981 Oct; 77(7):110-3. PubMed ID: 7341675 [No Abstract] [Full Text] [Related]
46. The effects of oestrogens on bluing lesions by bradykinin and histamine. Ishioka T; Honda Y; Sagara A; Shimamoto T Acta Endocrinol (Copenh); 1969 Feb; 60(2):177-83. PubMed ID: 4389899 [No Abstract] [Full Text] [Related]
47. [Comparative evaluation of the treatment of dysfunctional uterine hemorrhages based on data from the Armenian Institute of Obstetrics and Gynecology]. Melik-Alaverdian NI; Kagramanian RG; Khachatrian ML; Eolian ES; Kalantarova EG Zh Eksp Klin Med; 1972; 12(2):86-93. PubMed ID: 4662171 [No Abstract] [Full Text] [Related]
48. Clinical and cytologic responses of postmenopausal women to estrogen. Lin TJ; So-Bosita JL; Brar HK; Roblete BV Obstet Gynecol; 1973 Jan; 41(1):97-107. PubMed ID: 4345382 [No Abstract] [Full Text] [Related]
49. [Use of conjugated estrogens in diabetic retinopathy]. Németh L Klin Monbl Augenheilkd; 1969 Oct; 155(4):543-8. PubMed ID: 4315571 [No Abstract] [Full Text] [Related]
51. Conjugated estrogens for the management of gastrointestinal bleeding secondary to uremia of acute renal failure. Heunisch C; Resnick DJ; Vitello JM; Martin SJ Pharmacotherapy; 1998; 18(1):210-7. PubMed ID: 9469696 [TBL] [Abstract][Full Text] [Related]
52. [Proliferation dosage and threshold dosage of conjugated estrogens]. Kraus H; Heinen G; Mootz M Geburtshilfe Frauenheilkd; 1971 Jul; 31(7):669-77. PubMed ID: 4327502 [No Abstract] [Full Text] [Related]
53. [Blood coagulation-fibrinolysis and the pathology of the endometrium in functional uterine bleeding]. Matsuura R Sanfujinka No Jissai; 1967 Dec; 16(13):1301-12. PubMed ID: 5632218 [No Abstract] [Full Text] [Related]
54. [On the behavior of the hemostatic system during hormonal treatment of menstruation disorders]. Musiatowicz J; Bielecki M; Jezuita J; Wielkopolan J Wiad Lek; 1968 Jul; 21(13):1119-23. PubMed ID: 5670518 [No Abstract] [Full Text] [Related]
56. [Psychometric aspects of estrogen therapy in climacteric woman (study of 122 women after menopause]. Wenderlein JM Z Klin Psychol Psychother; 1981; 29(3):263-7. PubMed ID: 6274104 [No Abstract] [Full Text] [Related]